Physician profile
Henry K Lee
NPI 1548224447
$7,866.43
in general payments reported to CMS, 2019-2025
59 companies · $2,026 in 2025
The $2,026 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,663 · 2020: $530 · 2021: $760 · 2022: $594 · 2023: $342 · 2024: $952 · 2025: $2,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,067 · Education: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,066.57 |
| Education | $253.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $780.16 | 2019-2025 | Imfinzi, Enhertu |
| Pfizer INC. | $655.72 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $635.01 | 2019-2025 | |
| Janssen Biotech, INC. | $487.59 | 2019-2025 | Erleada, Rybrevant |
| Astellas Pharma US INC | $399.52 | 2019-2025 | Vyloy |
| Merck Sharp & Dohme LLC | $330.63 | 2019-2025 | Keytruda, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $326.85 | 2019-2022 | |
| Amgen INC. | $319.31 | 2019-2024 | |
| Array Biopharma INC | $302.22 | 2019-2025 | Braftovi, Mektovi, Tukysa |
| Kite Pharma, INC. | $278.57 | 2021-2023 | Yescarta |
| Bayer Healthcare Pharmaceuticals INC. | $241.37 | 2019-2025 | |
| Genentech USA, INC. | $225.00 | 2019-2025 | |
| Inari Medical, INC. | $195.45 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Eisai INC. | $166.70 | 2019-2025 | |
| Lilly USA, LLC | $165.72 | 2019-2021 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.